Gentherm Partners With ThermoAnalytics To Improve Thermal Comfort Predictions
Merck To Present Data From Three Cohorts Of Phase 1b/2 KEYNOTE-365 Study
West Pharma Q4 Reported EPS $0.69; Adj EPS $0.73
Novartis Receives FDA Approval For Egaten For Treatment Of Fascioliasis
Johnson & Johnson: Ethicon Enters Definitive Agreement To Acquire Auris Health
Teva Q4 Non-GAAP EPS $0.53, GAAP Loss Per Share $2.85
Clinigen Group Signs Agreement With Novartis To Acquire US Rights To Proleukin